Viral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules.

Charles T Spencer, Jelena S Bezbradica, Mireya G Ramos, Chenoa D Arico, Stephanie B Conant, Pavlo Gilchuk, Jennifer J Gray, Mu Zheng, Xinnan Niu, William Hildebrand, Andrew J Link, Sebastian Joyce

Journal: Proteomics. Clinical applications 2016;9(11-12):1035-52

PMID: 26768311

Abstract

PURPOSE

MHC class I presentation of peptides allows T cells to survey the cytoplasmic protein milieu of host cells. During infection, presentation of self peptides is, in part, replaced by presentation of microbial peptides. However, little is known about the self peptides presented during infection, despite the fact that microbial infections alter host cell gene expression patterns and protein metabolism.

EXPERIMENTAL DESIGN

The self peptide repertoire presented by HLA-A*01;01, HLA-A*02;01, HLA-B*07;02, HLA-B*35;01, and HLA-B*45;01 (where HLA is human leukocyte antigen) was determined by tandem MS before and after vaccinia virus infection.

RESULTS

We observed a profound alteration in the self peptide repertoire with hundreds of self peptides uniquely presented after infection for which we have coined the term "self peptidome shift." The fraction of novel self peptides presented following infection varied for different HLA class I molecules. A large part (approximately 40%) of the self peptidome shift arose from peptides derived from type I interferon-inducible genes, consistent with cellular responses to viral infection. Interestingly, approximately 12% of self peptides presented after infection showed allelic variation when searched against approximately 300 human genomes.

CONCLUSION AND CLINICAL RELEVANCE

Self peptidome shift in a clinical transplant setting could result in alloreactivity by presenting new self peptides in the context of infection-induced inflammation.

© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Address: Department of Biological Sciences, University of Texas at El Paso, El Paso, TX, USA.; Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia.; Department of Pathology, Microbiology and Immunology, Nashville, TN, USA.; Veterans Administration Tennessee Valley Healthcare System, Nashville, TN, USA.; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA.; Department of Microbiology and Immunology, University of Oklahoma Health Science Centre, Oklahoma City, OK, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.